Dognosis pairs trained dogs with an AI reader to prescreen breath samples for more than 20 cancers
Bengaluru startup Dognosis trains dogs to detect the volatile organic compounds that cancers push into a person's breath, and uses sensors plus an AI model to translate the dogs' movement, respiration and body language into standardized results instead of a handler's read. In its published Phase 2 study, seven trained dogs identified more than 90% of cancers and more than 91% of non-cancer samples across seven cancer groups covering 20+ cancer types, with similar performance on early-stage disease. A Phase 3 trial started in April across 10 Indian hospitals, aiming to enroll roughly 10,000 people; the long-term plan is about 30 dogs supporting up to a million tests a year. It is a prescreening tool, not a diagnosis.